This report studies Hereditary Angioedema Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2014 to 2019, and forecast to 2025.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
By Product
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
By Route of Administration
Oral
Intravenous
Subcutaneous Injection
By Application, the market can be split into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Hereditary Angioedema Drug Market Professional Survey Report 2019
1 Industry Overview of Hereditary Angioedema Drug
1.1 Definition and Specifications of Hereditary Angioedema Drug
1.1.1 Definition of Hereditary Angioedema Drug
1.1.2 Specifications of Hereditary Angioedema Drug
1.2 Classification of Hereditary Angioedema Drug
1.2.1 C1 Esterase Inhibitor
1.2.2 Kallikrein Inhibitor
1.2.3 Selective Bradykinin B2 Receptor Antagonist
1.3 Applications of Hereditary Angioedema Drug
1.3.1 Retail Pharmacies
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Hereditary Angioedema Drug
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hereditary Angioedema Drug
2.3 Manufacturing Process Analysis of Hereditary Angioedema Drug
2.4 Industry Chain Structure of Hereditary Angioedema Drug
3 Technical Data and Manufacturing Plants Analysis of Hereditary Angioedema Drug
3.1 Capacity and Commercial Production Date of Global Hereditary Angioedema Drug Major Manufacturers in 2018
3.2 Manufacturing Plants Distribution of Global Hereditary Angioedema Drug Major Manufacturers in 2018
3.3 R&D Status and Technology Source of Global Hereditary Angioedema Drug Major Manufacturers in 2018
3.4 Raw Materials Sources Analysis of Global Hereditary Angioedema Drug Major Manufacturers in 2018
4 Global Hereditary Angioedema Drug Overall Market Overview
4.1 2014-2019E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2014-2019E Global Hereditary Angioedema Drug Capacity and Growth Rate Analysis
4.2.2 2018 Hereditary Angioedema Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2014-2019E Global Hereditary Angioedema Drug Sales and Growth Rate Analysis
4.3.2 2018 Hereditary Angioedema Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2014-2019E Global Hereditary Angioedema Drug Sales Price
4.4.2 2018 Hereditary Angioedema Drug Sales Price Analysis (Company Segment)
5 Hereditary Angioedema Drug Regional Market Analysis
5.1 North America Hereditary Angioedema Drug Market Analysis
5.1.1 North America Hereditary Angioedema Drug Market Overview
5.1.2 North America 2014-2019E Hereditary Angioedema Drug Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2014-2019E Hereditary Angioedema Drug Sales Price Analysis
5.1.4 North America 2018 Hereditary Angioedema Drug Market Share Analysis
5.2 China Hereditary Angioedema Drug Market Analysis
5.2.1 China Hereditary Angioedema Drug Market Overview
5.2.2 China 2014-2019E Hereditary Angioedema Drug Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2014-2019E Hereditary Angioedema Drug Sales Price Analysis
5.2.4 China 2018 Hereditary Angioedema Drug Market Share Analysis
5.3 Europe Hereditary Angioedema Drug Market Analysis
5.3.1 Europe Hereditary Angioedema Drug Market Overview
5.3.2 Europe 2014-2019E Hereditary Angioedema Drug Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2014-2019E Hereditary Angioedema Drug Sales Price Analysis
5.3.4 Europe 2018 Hereditary Angioedema Drug Market Share Analysis
5.4 Southeast Asia Hereditary Angioedema Drug Market Analysis
5.4.1 Southeast Asia Hereditary Angioedema Drug Market Overview
5.4.2 Southeast Asia 2014-2019E Hereditary Angioedema Drug Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2014-2019E Hereditary Angioedema Drug Sales Price Analysis
5.4.4 Southeast Asia 2018 Hereditary Angioedema Drug Market Share Analysis
5.5 Japan Hereditary Angioedema Drug Market Analysis
5.5.1 Japan Hereditary Angioedema Drug Market Overview
5.5.2 Japan 2014-2019E Hereditary Angioedema Drug Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2014-2019E Hereditary Angioedema Drug Sales Price Analysis
5.5.4 Japan 2018 Hereditary Angioedema Drug Market Share Analysis
5.6 India Hereditary Angioedema Drug Market Analysis
5.6.1 India Hereditary Angioedema Drug Market Overview
5.6.2 India 2014-2019E Hereditary Angioedema Drug Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2014-2019E Hereditary Angioedema Drug Sales Price Analysis
5.6.4 India 2018 Hereditary Angioedema Drug Market Share Analysis
6 Global 2014-2019E Hereditary Angioedema Drug Segment Market Analysis (by Type)
6.1 Global 2014-2019E Hereditary Angioedema Drug Sales by Type
6.2 Different Types of Hereditary Angioedema Drug Product Interview Price Analysis
6.3 Different Types of Hereditary Angioedema Drug Product Driving Factors Analysis
6.3.1 By Product of Hereditary Angioedema Drug Growth Driving Factor Analysis
6.3.2 By Route of Administration of Hereditary Angioedema Drug Growth Driving Factor Analysis
7 Global 2014-2019E Hereditary Angioedema Drug Segment Market Analysis (by Application)
7.1 Global 2014-2019E Hereditary Angioedema Drug Consumption by Application
7.2 Different Application of Hereditary Angioedema Drug Product Interview Price Analysis
7.3 Different Application of Hereditary Angioedema Drug Product Driving Factors Analysis
7.3.1 Retail Pharmacies of Hereditary Angioedema Drug Growth Driving Factor Analysis
7.3.2 Hospital Pharmacies of Hereditary Angioedema Drug Growth Driving Factor Analysis
7.3.3 Online Pharmacies of Hereditary Angioedema Drug Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Hereditary Angioedema Drug
8.1 Pharming Group NV
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Pharming Group NV 2018 Hereditary Angioedema Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Pharming Group NV 2018 Hereditary Angioedema Drug Business Region Distribution Analysis
8.2 Shire plc
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Shire plc 2018 Hereditary Angioedema Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Shire plc 2018 Hereditary Angioedema Drug Business Region Distribution Analysis
8.3 CSL Limited
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 CSL Limited 2018 Hereditary Angioedema Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 CSL Limited 2018 Hereditary Angioedema Drug Business Region Distribution Analysis
8.4 iBio Inc.
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 iBio Inc. 2018 Hereditary Angioedema Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 iBio Inc. 2018 Hereditary Angioedema Drug Business Region Distribution Analysis
8.5 BioCryst Pharmaceuticals, Inc.
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 BioCryst Pharmaceuticals, Inc. 2018 Hereditary Angioedema Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 BioCryst Pharmaceuticals, Inc. 2018 Hereditary Angioedema Drug Business Region Distribution Analysis
8.6 Ionis Pharmaceuticals, Inc.
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Ionis Pharmaceuticals, Inc. 2018 Hereditary Angioedema Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Ionis Pharmaceuticals, Inc. 2018 Hereditary Angioedema Drug Business Region Distribution Analysis
9 Development Trend of Analysis of Hereditary Angioedema Drug Market
9.1 Global Hereditary Angioedema Drug Market Trend Analysis
9.1.1 Global 2019-2022 Hereditary Angioedema Drug Market Size (Volume and Value) Forecast
9.1.2 Global 2019-2022 Hereditary Angioedema Drug Sales Price Forecast
9.2 Hereditary Angioedema Drug Regional Market Trend
9.2.1 North America 2019-2022 Hereditary Angioedema Drug Consumption Forecast
9.2.2 China 2019-2022 Hereditary Angioedema Drug Consumption Forecast
9.2.3 Europe 2019-2022 Hereditary Angioedema Drug Consumption Forecast
9.2.4 Southeast Asia 2019-2022 Hereditary Angioedema Drug Consumption Forecast
9.2.5 Japan 2019-2022 Hereditary Angioedema Drug Consumption Forecast
9.2.6 India 2019-2022 Hereditary Angioedema Drug Consumption Forecast
9.3 Hereditary Angioedema Drug Market Trend (Product Type)
9.4 Hereditary Angioedema Drug Market Trend (Application)
10 Hereditary Angioedema Drug Marketing Type Analysis
10.1 Hereditary Angioedema Drug Regional Marketing Type Analysis
10.2 Hereditary Angioedema Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Hereditary Angioedema Drug by Region
10.4 Hereditary Angioedema Drug Supply Chain Analysis
11 Consumers Analysis of Hereditary Angioedema Drug
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Hereditary Angioedema Drug Market Professional Survey Report 2019
Methodology
Analyst Introduction
Data Source
Request Discount 
Inquire Before Buy
